Related Experiment Video
Updated: Jul 24, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Clinical trials: the past, a lesson for the future
1Hĵpital de la Salpêtrière, Paris, France. vincent.meininger@psl.ap-hop-paris.fr
Summary
Numerous amyotrophic lateral sclerosis (ALS) drug trials yielded negative results, yet no treatments or mechanisms can be definitively excluded. Future research requires realistic expectations and improved trial design for better outcomes.
Area of Science:
- Neuroscience
- Clinical Pharmacology
- Drug Development
Background:
- Amyotrophic lateral sclerosis (ALS) research has extensively tested various drugs.
- The primary goal was to identify effective treatments and elucidate disease mechanisms.
- Most clinical trials for ALS drugs have historically reported negative outcomes.
Purpose of the Study:
- To analyze past drug trial data in ALS.
- To reassess the efficacy of tested drugs and underlying disease mechanisms.
- To identify key factors for improving future clinical trial design and success rates.
Main Methods:
- Comprehensive review and analysis of previous amyotrophic lateral sclerosis drug trials.
- Critical evaluation of trial endpoints and statistical power calculations.
- Assessment of the current understanding of ALS pharmacology.
Main Results:
- Despite negative trial results, no specific drug or proposed mechanism for ALS can be conclusively dismissed.
- Analysis indicates a need for re-evaluation rather than outright rejection of previously tested interventions.
- Existing data suggests potential flaws in trial design and interpretation.
Conclusions:
- Future amyotrophic lateral sclerosis (ALS) drug development requires realistic expectations regarding treatment efficacy.
- Clearly defined clinical trial endpoints and adequate statistical power are crucial for successful research.
- Enhanced understanding of ALS pharmacology is essential for advancing therapeutic strategies.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.